SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON.
| Revenue (Most Recent Fiscal Year) | $77.27M |
| Net Income (Most Recent Fiscal Year) | $-79.00M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 8.20 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 8.50 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -93.19% |
| Net Margin (Trailing 12 Months) | -93.86% |
| Return on Equity (Trailing 12 Months) | -132.47% |
| Return on Assets (Trailing 12 Months) | -45.97% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.69 |
| Quick Ratio (Most Recent Fiscal Quarter) | 2.55 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.58 |
| Inventory Turnover (Trailing 12 Months) | 4.23 |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.99 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.26 |
| Earnings per Share (Most Recent Fiscal Year) | $-1.17 |
| Diluted Earnings per Share (Trailing 12 Months) | $-1.15 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Health Information Services |
| Common Shares Outstanding | 83.89M |
| Free Float | 79.80M |
| Market Capitalization | $706.82M |
| Average Volume (Last 20 Days) | 0.55M |
| Beta (Past 60 Months) | 0.98 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 4.88% |
| Percentage Held By Institutions (Latest 13F Reports) | 31.59% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |